Kazakhstan vs Mus: Hypertension treatment coverage among adults aged 30-79 with
Kazakhstan
70.5%
in 2019
Mus
60.2%
in 2019
Kazakhstan rank
4th
Mus rank
1st
Hypertension treatment coverage among adults aged 30-79 with over time
- Kazakhstan
- Mus
How they compare
Kazakhstan currently reports 70.5% against 60.2% in Mus, a difference of 10.3%.
That makes Kazakhstan's figure about 1.2 times Mus's.
Across all 30 years both countries report, Kazakhstan has been ahead every year.
Kazakhstan ranks 4th and Mus ranks 1st of 193 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Mus | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 43.9% | 33.8% | 10.1% | Kazakhstan |
| 2000s | 56.8% | 42.7% | 14.1% | Kazakhstan |
| 2010s | 67.2% | 54.5% | 12.6% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension treatment coverage among adults aged 30-79 with, Kazakhstan or Mus?
- Kazakhstan, at 70.5% against 60.2% in Mus as of 2019.
- What is the difference in hypertension treatment coverage among adults aged 30-79 with between Kazakhstan and Mus?
- 10.3%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Mus?
- 30 years are reported by both, from 1990 to 2019.
- How do Kazakhstan and Mus rank globally for hypertension treatment coverage among adults aged 30-79 with?
- Kazakhstan ranks 4th and Mus ranks 1st of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.